On January 9, 2025, the federal government announced a new Canada Health Act (CHA) Services Policy that will take effect on April 1, 2026. The policy addresses a long-standing gap in Canadian healthcare: when a medically necessary service is covered under a provincial health plan because a physician provides it, patients should not be charged out of pocket for the same service when it is provided by another regulated health professional, including pharmacists.
The Problem the Policy Solves
Canada's healthcare system was designed around a physician-centric model. The Canada Health Act, originally passed in 1984, guarantees coverage for "medically necessary" hospital and physician services. Over the past four decades, the scope of practice for pharmacists, nurse practitioners, midwives, and other health professionals has expanded dramatically, but the funding model has not kept pace.
The result has been inconsistency. A patient who sees a physician for a minor ailment assessment pays nothing. The same patient receiving the same assessment from a pharmacist may or may not be charged, depending on the province, the service, and the funding arrangement in place. In some cases, patients avoid pharmacist-provided services simply because they carry a fee, even when the pharmacist is the most accessible and appropriate provider.
This creates a two-tier dynamic that undermines the principle of universality at the heart of the CHA.
What the New Policy Requires
The CHA Services Policy establishes a clear principle: if a service is medically necessary and insured when a physician performs it, patients must not face charges when the same service is delivered by a regulated health professional acting within their authorized scope of practice.
This applies to a range of services that pharmacists across Canada are increasingly authorized to provide, including minor ailment prescribing, prescription renewals and adaptations, chronic disease management consultations, medication reviews and therapy optimization, immunizations, and point-of-care testing and screening.
The policy does not expand pharmacists' scope of practice directly. That authority rests with provincial and territorial regulatory bodies. What it does is ensure that when pharmacists are authorized to provide a service, and that service is deemed medically necessary, the patient is not financially penalized for choosing a pharmacist over a physician.
How Provinces Will Need to Respond
Implementation will vary across jurisdictions. Some provinces, like Alberta and Nova Scotia, already reimburse pharmacists for a broad range of clinical services and may require only modest adjustments. Others will need to develop new fee schedules, billing codes, and administrative processes to comply with the policy by the April 2026 deadline.
The federal government has indicated that compliance with the new policy will be a condition of full Canada Health Transfer (CHT) payments. Provinces that fail to eliminate patient charges for covered services provided by regulated health professionals could face financial penalties, consistent with the CHA's existing enforcement mechanisms.
Implications for Pharmacy Practice
For pharmacists, the policy represents formal recognition of their clinical role within the publicly funded healthcare system. It moves pharmacist services from the periphery of insured healthcare into the core framework of the CHA.
Practically, this means pharmacists can expect increased patient volumes for clinical services, as the financial barrier to accessing pharmacist care is removed. It also means increased administrative requirements, including documentation and billing processes that align with provincial health insurance plan standards.
Pharmacy owners and managers will need to prepare for these changes. Staff scheduling, workflow design, and technology systems may all require updates to accommodate higher demand for clinical services.
A Step Toward Team-Based Care
The CHA Services Policy reflects a broader shift in Canadian healthcare toward interprofessional, team-based models. By ensuring that funding follows the service rather than the provider type, the policy removes a structural incentive to funnel all care through physicians and supports a more distributed, accessible system.
For patients, particularly those in rural and underserved communities where pharmacists may be the most readily available healthcare provider, this change could meaningfully improve access to care.
At PlusVirtual, we see this policy as validation of what community pharmacists have long demonstrated: that they deliver safe, effective, and essential clinical services. Ensuring those services are funded equitably is not just good policy. It is the foundation of a healthcare system that works for everyone.